Provided by Tiger Trade Technology Pte. Ltd.

Arcturus Therapeutics Ltd.

7.30
-0.7400-9.20%
Post-market: 7.300.00000.00%18:49 EDT
Volume:412.10K
Turnover:3.07M
Market Cap:207.41M
PE:-2.57
High:8.02
Open:7.96
Low:7.23
Close:8.04
52wk High:24.17
52wk Low:5.85
Shares:28.41M
Float Shares:26.28M
Volume Ratio:0.84
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8392
EPS(LYR):-2.4021
ROE:-37.01%
ROA:-19.14%
PB:1.08
PE(LYR):-3.04

Loading ...

Arcturus Therapeutics to Present at Jefferies Global Healthcare Conference

Reuters
·
May 27

ARCT Rating Reiterated at Hold as High-Risk ARCT-032 CF Program Awaits Binary Phase 2 Readout; $9 Price Target Maintained

TIPRANKS
·
May 13

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
May 12

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Arcturus Therapeutics Holdings Inc - Appoints Dennis Mulroy as CFO Effective May 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Arcturus Therapeutics CFO Dennis Mulroy files initial beneficial ownership statement

Reuters
·
May 08

Arcturus Q1 FY26 net loss widens to $27 million; revenue drops to $2.06 million

Reuters
·
May 08

BRIEF-Arcturus Therapeutics Q1 Net Income USD -26.964 Million

Reuters
·
May 08

Arcturus Therapeutics Q1 Collaboration Revenue USD 610 Thousand

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Arcturus Therapeutics Holdings Inc expected to post a loss of $1.09 a share - Earnings Preview

Reuters
·
May 06

Arcturus Therapeutics updates financial calendar with first-quarter results conference call

Reuters
·
Apr 28

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28

Arcturus Therapeutics announces annual shareholder meeting

Reuters
·
Apr 25

Roth MKM Remains a Buy on Arcturus Therapeutics (ARCT)

TIPRANKS
·
Apr 15

Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
Mar 27

Arcturus Therapeutics Holdings Inc : B. Riley Initiates Coverage With Buy Rating; Price Target $22

THOMSON REUTERS
·
Mar 18

Arcturus Therapeutics initiated with a Buy at B. Riley

TIPRANKS
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18

Arcturus Therapeutics to Join Leerink Partners 2026 Global Healthcare Conference Fireside Chat

Reuters
·
Mar 05